These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 6300953)

  • 1. [Comparative evaluation of the antibacterial activity of cefotaxime and cephalotin by using an automated antimicrobial susceptibility determination system].
    Concia E; Marone P; Dos Santos C; Bono L
    Quad Sclavo Diagn; 1982 Jun; 18(2):223-32. PubMed ID: 6300953
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Study of the minimum inhibiting concentration of a new cephalosporin (HR 756): comparative data with other beta-lactamic antibiotics].
    Mascellino MT; Prignano G; Iegri F; Delia S
    Boll Ist Sieroter Milan; 1981 May; 60(2):102-9. PubMed ID: 6272823
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro antibacterial activity of a new 1-oxa cephalosporin compound.
    Downs JT; Andriole VT
    Yale J Biol Med; 1980; 53(2):149-59. PubMed ID: 6446810
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [In vitro activity of cefatiolene (RP 42,980) against hospital bacteria. Comparison with cefotaxime and lamoxactam. Results of a multicenter study].
    Duval J; Soussy CJ; Deforges L; Le Van Thoi J; Acar JF; Kitzis D; Dabernat H; Christol D; Bure A; Courtieu AL
    Pathol Biol (Paris); 1983 May; 31(5):357-61. PubMed ID: 6312397
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibacterial activity of aztreonam: a synthetic monobactam. A comparative study with thirteen other antibiotics.
    Paradelis AG; Stathopoulos GA; Salpigides GN; Crassaris LG
    Methods Find Exp Clin Pharmacol; 1983; 5(6):375-83. PubMed ID: 6684718
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison between the efficacy of cefotaxime and cephalothin on several infections by gram (+) and gram(-) bacteria.
    Huerta MD; Valenzuela F
    Proc West Pharmacol Soc; 1991; 34():373-8. PubMed ID: 1788318
    [No Abstract]   [Full Text] [Related]  

  • 7. Susceptibility of bacterial isolates to cefepime in comparison to other broad spectrum antimicrobial agents at a tertiary care center in Lebanon.
    Kanj SS; Chedid M; Araj GF
    J Med Liban; 2001; 49(1):13-7. PubMed ID: 11910959
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Continuous surveillance of antimicrobial resistance among nosocomial gram-negative bacilli from intensive care units in China].
    Chen MJ; Wang H;
    Zhonghua Yi Xue Za Zhi; 2003 Mar; 83(5):375-81. PubMed ID: 12820912
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Distribution and drug-resistance of 3 500 gram-negative bacteria in Guangzhou].
    Xiao QZ; Su DH; Jiang JH; Zhong NS
    Di Yi Jun Yi Da Xue Xue Bao; 2005 Feb; 25(2):132-8. PubMed ID: 15698988
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Surveillance of antimicrobial resistance among nosocomial gram-negative pathogens from 15 teaching hospitals in China in 2005].
    Yang QW; Xu YC; Chen MJ; Hu YJ; Ni YX; Sun JY; Yu YS; Kong HS; He L; Wu WY; Ye HF; Yang YM; Zhu LN; Guo SH; Ji P; Zhu ZH; Ren JK; Zhang LX; Sun ZY; Zhu XH; Tong MQ; Zhao WS; Mei YN; Liu Y; Zhang ZJ; Duan Q; Li D; Liu PP; Wang J; Han LX; Wang H; Xie XL
    Zhonghua Yi Xue Za Zhi; 2007 Oct; 87(39):2753-8. PubMed ID: 18167265
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparisons of parenteral broad-spectrum cephalosporins tested against bacterial isolates from pediatric patients: report from the SENTRY Antimicrobial Surveillance Program (1998-2004).
    Jones RN; Sader HS; Fritsche TR; Pottumarthy S
    Diagn Microbiol Infect Dis; 2007 Jan; 57(1):109-16. PubMed ID: 16930923
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cefotaxime: clinical and bacteriologic evaluation.
    Saroglou G; Paniara-Volika O; Sima A; Koltsida K; Rokas S; Kontomichalou P
    Clin Ther; 1981; 4(3):201-11. PubMed ID: 6272994
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the in vitro activity of 9 antimicrobials against bacterial strains isolated from patients in intensive care units in brazil: MYSTIC Antimicrobial Surveillance Program.
    Mendes C; Hsiung A; Kiffer C; Oplustil C; Sinto S; Mimica I; Zoccoli C;
    Braz J Infect Dis; 2000 Oct; 4(5):236-44. PubMed ID: 11063555
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Concentration-dependency of beta-lactam-induced filament formation in Gram-negative bacteria.
    Buijs J; Dofferhoff AS; Mouton JW; Wagenvoort JH; van der Meer JW
    Clin Microbiol Infect; 2008 Apr; 14(4):344-9. PubMed ID: 18261128
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Prevalence of extended-spectrum beta-lactamases in nosocomial Escherichia coli and Klebsiella spp. strains isolated from blood cultures].
    Zarakolu P; Metan G; Hasçelik G; Akova M
    Mikrobiyol Bul; 2007 Oct; 41(4):579-84. PubMed ID: 18173077
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro susceptibility pattern of cephalosporin-resistant Gram-negative bacteria.
    Punpanich W; Tantichattanon W; Wongwatcharapaiboon S; Treeratweeraphong V
    J Med Assoc Thai; 2008 Oct; 91 Suppl 3():S21-7. PubMed ID: 19255989
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of the activity in vitro of different cephalosporins: cephalothin, cephradine, cephacetrile, cefaclor, cefuroxime and cefotaxime.
    Bianchi P; Frongillo RF
    Boll Ist Sieroter Milan; 1980 Jan; 58(6):488-95. PubMed ID: 6255966
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro activity of ceftazidime and ceftriaxone.
    Keenholtz SL; Jacobus NV; Tally FP; Gorbach SL
    Clin Ther; 1983; 5(6):603-16. PubMed ID: 6313195
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of the in vitro activity of cefoxitin and cephalothin against 7,312 clinical isolates.
    Lingaas E; Midtvedt T; Melby K; Dahl OU
    Chemotherapy; 1981; 27(4):239-46. PubMed ID: 7249786
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative in vitro and in vivo activity of cefminox (MT-141), cefotaxime and cefoperazone against gram-negative bacteria.
    Watanabe T; Kazuno Y; Hirano F; Inouye S; Nishino T
    Drugs Exp Clin Res; 1985; 11(11):781-6. PubMed ID: 3841789
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.